Shamrock Medicaments (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-12-2024
- Paid Up Capital ₹ 0.50 M
as on 08-12-2024
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.60 M
as on 08-12-2024
- Revenue -46.83%
(FY 2021)
- Profit -59.77%
(FY 2021)
- Ebitda 64.98%
(FY 2021)
- Net Worth 11.63%
(FY 2021)
- Total Assets -4.73%
(FY 2021)
About Shamrock Medicaments (India)
The Corporate was formerly known as Doctor Lifeline Remedies (India) Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.60 M.
Sangini Khokhani, Kalpesh Khokhani, and Jitesh Rameshchandra serve as directors at the Company.
- CIN/LLPIN
U51397MH2001PLC133209
- Company No.
133209
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Shamrock Medicaments (India) Limited offer?
Shamrock Medicaments (India) Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at Shamrock Medicaments (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpesh Khokhani  | Director | 30-Aug-2018 | Current |
| Jitesh Rameshchandra | Director | 01-Dec-2006 | Current |
| Sangini Khokhani | Director | 01-Dec-2006 | Current |
Financial Performance and Corporate Structure Insights of Shamrock Medicaments (India).
Shamrock Medicaments (India) Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 46.83% decrease. The company also saw a substantial fall in profitability, with a 59.77% decrease in profit. The company's net worth Soared by an impressive increase of 11.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shamrock Medicaments (India)?
In 2021, Shamrock Medicaments (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shamrock Industrial Company LimitedActive 33 years 5 monthsKalpesh Khokhani and Jitesh Rameshchandra are mutual person
- Shamrock Finlease LimitedActive 34 years 9 days
Kalpesh Khokhani and Jitesh Rameshchandra are mutual person
- Shamrock Advertising And Publishing Company Pvt LtdActive 33 years 5 months
Kalpesh Khokhani and Jitesh Rameshchandra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Oct 2021 | ₹2.60 M | Open |
How Many Employees Work at Shamrock Medicaments (India)?
Unlock and access historical data on people associated with Shamrock Medicaments (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shamrock Medicaments (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shamrock Medicaments (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
